Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
iShares Biotechnology ETF
IBB performance and flow charts
Performance
Flows
Historic performance and flows
Data as of April 27, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +5.31% | -4.45% | +0.16% | +35.85% | +31.87% | +8.56% |
| Flows | -$138M | -$331M | -$327M | +$772M | -$1.59B | -$2.08B |
Characteristics
The iShares Biotechnology ETF is built to track the ICE Biotechnology Index (TR) - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Strategy | Long Only |
| Provider | iShares |
| N° of holdings | 249 |
| Replication method | Direct (Physical) |
| Asset class | Equity |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | February 5, 2001 |
| ESG | No |
More data and info about IBB on Trackinsight
Exposure
Data as of March 31, 2026Diversification
Total weight of top 15 holdings out of 249
Top 15 Holdings
Sectors
Countries
Latest news about IBB
Similar ETFs
Trading data
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +22.34% | +21.20% | +19.78% | +22.09% |
Max drawdown | -9.27% | -9.61% | -24.82% | -39.75% |
Max drawdown duration | 90d | 95d | 377d | 1611d |
Time to recover | N/A | N/A | 177d | 1301d |
Replication quality
Data as of March 31, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
What type of ETF is IBB?
IBB is a Passive ETF that provides exposure to Equity assets. It is managed by iShares.
What index does IBB track?
IBB tracks the ICE Biotechnology Index (TR) - USD, aiming to replicate its performance through full replication.
What does IBB invest in?
This ETF provides exposure to US Biotechnology Equities. It is part of the segment: US Health Care.
What is the expense ratio of IBB?
The total expense ratio (TER) of IBB is 0.44%, representing the annual fee charged by the fund manager.
When was IBB launched?
IBB was launched on February 5, 2001, marking its entry into the ETF market.
Who is the issuer of IBB?
IBB is issued by iShares.
What is the AUM of IBB?
As of April 27, 2026, IBB manages $8.03 B, reflecting the total assets held in the fund.
How has IBB performed recently?
As of April 27, 2026, IBB delivered a return of 5.31% over the past month (1M performance), -4.45% over the past three months (3M), and 0.16% year-to-date (YTD).
What are the recent fund flows for IBB?
As of April 27, 2026, IBB has seen net flows of -$138M in the past month (1M flow) and -$327M year-to-date (YTD).
Does IBB pay dividends?
As of April 27, 2026, IBB has a trailing 12-month distribution yield of 0.23%.
How many holdings are in IBB
As of March 31, 2026, IBB holds 249 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is IBB?
As of March 31, 2026, IBB holds 249 securities, with 55.88% of its assets concentrated in its top 15 holdings.
What are the top holdings of IBB?
As of March 31, 2026, IBB holds a portfolio of 249 underlyings, with its largest positions including GILEAD SCIENCES, AMGEN-T and VERTEX PHARMACEUTICALS. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does IBB invest in?
As of March 31, 2026, IBB has its largest geographic exposures in USA.
What sectors or themes does IBB focus on?
As of March 31, 2026, IBB is primarily exposed to Health Care.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
What’sTheFund
What's the Fund | State Street SPDR IG Public & Private Credit ETF (Ticker: PRIV)
Matthew Bartolini, Global Head of Research Strategists, at State Street Investment Management, joins Ethan Hertzfeld on the New York Stock Exchange Floor to discuss PRIV, the State Street SPDR IG Public & Private Credit ETF.
ETF Trends
ETF Industry KPIs April 27, 2026
The ETF Industry saw 23 New Launches, 1 Ticker Change and 4 closures last week.
Asset TV
The ETF Show - Investors Can Fight Healthcare Inflation with Newly Launched ETFs
Adam Schenck, Principal and Managing Director of Fund Services at Milliman joined The ETF Show to discuss Milliman's first ETFs designed to hedge against rising healthcare inflation.
ETF Trends
ETF Industry KPIs April 20, 2026
The ETF Industry saw 14 New Launches, 1 Ticker Change and 16 closures last week.
Browse all educational columns
Build and Analyze Your ETF Portfolio Like a Pro
Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.
